跳至主要内容
临床试验/EUCTR2009-010861-21-IT
EUCTR2009-010861-21-IT进行中(未招募)不适用

Evaluation of the bilo-enteric anastomoses with contrast-enhanced MR-cholangiopancreatography (MRCP) with PRIMOVIST (Gd-EOB-DTPA-enhanced MRCP): comparison with conventional T2-weighted MRCP. - ND

AZIENDA OSPEDALIERA PISANA0 个研究点开始时间: 2009年4月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Adult (18 years and older) patients (men or women of any ethnic group). 2. Patients with clinical-echographical suspect of biliary pathology. 3. Patients with pre-existing bilo-enteric anastomoses. 4. Patients willing and able to undergo all study procedures. 5. Women in fertile age that use contraceptives. 6. Patients who have signed the written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Pregnant or lactating women. 2. Patients with less than 3 months life expectation. 3. Patients presenting with contraindication to MR. 4. Patients with cardiac pacemakers and ferromagnetic implants 5. Patients taking class III antiarrhythmic and rifampicin 6. Patients with uncorrected hypokalemia or hypopotassemia 7. History of allergic disorder (of any severity) or allergic reaction to MR contrast media. 8.Patients with history of bronchial asthma and severe cardiovascular problem 9. Uncooperative, in the investigator?s opinion. 10. Severe renal impairment (GFR< 30ml/min /1.73 m2). 11. Severe hepatic impairment. 12. Participating in another clinical trial.

研究者

发起方
AZIENDA OSPEDALIERA PISANA

相似试验

Evaluation of the bilo-enteric anastomoses with... | 临床试验